Personalized medicine & survival prediction

Personalized medicine & survival prediction

Robert Nagourney Robert A. Nagourney, MD, is Medical and Laboratory Director of The Nagourney Cancer Institute in Long Beach, California, Associate Clinical Professor, at University of California Irvine and founder and CEO of Metabolomycs, Inc.  He is board...
Multi-omics & type 2 diabetes

Multi-omics & type 2 diabetes

Sapna Sharma Sapna Sharma is group leader at Technical University Munich (TUM) in Germany Favorite metabolitelysophosphatidylcholines (LPCs) Papers we discussed in this episodeEffect of BMI on type 2 diabetes | Metabolic Signatures Elucidate the Effect of Body Mass...
Biobanks & neurodegenerative diseases

Biobanks & neurodegenerative diseases

Karel Kalecký Karel Kalecký is postdoctoral research associateat the Institute of Metabolic Disease, Baylor Scott & White Research Institute in Dallas, TX (USA) Favorite metaboliteBetaine (trimethylglycine) Papers we discussed in this episodeOne-Carbon Metabolism...